Where does Encore Medical, LP rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Encore Medical, LP ranks #5,583 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Encore Medical, LP hold?

Encore Medical, LP holds 61 US utility patents granted between 2016 and 2025, spanning 15 technology areas.

What is Encore Medical, LP's Innovation Score?

Encore Medical, LP has an Innovation Score of 44.5 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Encore Medical, LP's patent grant rate increasing or decreasing?

Encore Medical, LP's recent grant velocity is +167% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Encore Medical, LP's patents?

Encore Medical, LP's patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Encore Medical, LP patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Encore Medical, LP

Q: What technology areas does Encore Medical, LP focus on?

Encore Medical, LP's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 50 patents, ranking #118 of 3,082 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 61 granted patents across 15 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Encore ranks #5,583 of 49,997 tracked US assignees by granted-patent volume, with 61 patents across 15 technology areas.

#5,583
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.5/100): 15.9
avg claims per patent: +167%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5583 · US Corporation #5,583 · 61 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 61 grants
UPPER-Q #5,583/49,997
PHOTO-FINISH Danfoss Power A/S
CPC-FOCUS A61F · 15 areas
INNOV-PAR 44.5/100
CLAIMS-RICH 15.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +167% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Danfoss Power Electronics A/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Encore’s 44.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.3 pts (32%) Velocity 7.0 pts (16%) Breadth 13.7 pts (31%) Claim depth 9.6 pts (22%)

Qualcomm Incorporated · highest

85
ASM America · near

44
Celestica Technology… · near

44
Encore Medical · this assignee

44
University OF… · near

44
Zeno Semiconductor · near

44
3D Lighting… · lowest

7

What this shows Encore's Innovation Score is 44.5/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Encore?

Each dot is one of Encore’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Encore’s own 15.9 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Encore vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Encore's grants concentrate

Encore Medical, LP is a focused PatentsView assignee: 15 CPC subclasses with 82% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (11 grants) versus a trough of 2 in 2017. By volume, Encore sits between Danfoss Power Electronics A/S and Factor Bioscience Inc..

Encore's three-year grant acceleration

From 2019–2021 to 2022–2024, Encore Medical, LP moved from 22 to 23 grants (1.04x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Danfoss Power A/S

61
Deepx

61
Eltek S p A

61
Ember

61
Entrust Datacard

61
Florida Power & L…

61
Fuji Electric FA…

61
Factor Bioscience

61
Encore Medical ◀

61

What this shows Encore holds 61 patents at rank #5,582, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Encore

By rank, the assignees closest to #5,582 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Encore's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Encore, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Encore ranks #118 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

University OF Leicester 44 Celestica Technology Consultancy (Shanghai) Co. Ltd 44 Zeno Semiconductor, Inc. 44 ASM America, Inc. 44

Similar claim depth

Nearest assignees by average claims per patent (15.9 here).

Beijing Kuangshi Technology Co., Ltd. 15.9 avg Network-1 Technologies, Inc. 15.9 avg Vishay-Siliconix, LLC 15.9 avg Sony Pictures Entertainment Inc. 15.9 avg

Encore's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Encore Medical, LP patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	4.9%
2017	2	3.3%
2018	5	8.2%
2019	5	8.2%
2020	7	11.5%
2021	10	16.4%
2022	4	6.6%
2023	8	13.1%
2024	11	18.0%
2025partial year	6	9.8%

Which technologies does Encore Medical, LP patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 50

A61B - DIAGNOSIS; SURGERY; Identification 28

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 4

B29B - Preparation OR Pretreatment OF THE Material TO BE SHAPED; Making Granules OR PREFORMS; Recovery OF Plastics OR Other Constituents OF Waste Material Containing Plastics 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

Y10T - Technical Subjects Covered BY Former US Classification 4

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 3

G06F - Electric Digital Data Processing 3

B22F - Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

F16D - Couplings FOR Transmitting ROTATION; CLUTCHES; Brakes 2

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 2

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Encore Medical, LP's patent record in context - here's where to go next.

Encore Medical, LP's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 82% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #5,583 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Encore Medical, LP against Danfoss Power Electronics A/S, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.